Evidence map›Paper›PMID 34427801›Full record

ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Antimicrobial resistance in Clostridioides difficile.

Keeley O'Grady, Daniel R Knight, Thomas V Riley

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Spore-formingApplied and environmental microbiology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Pangenome-GWAS analysis ofCanadian journal of microbiology · 2026
    Article
  7. Frontiers in immunology · 2026
    Article
  8. Phenotypic and genotypic antimicrobial resistance profiles of clinical Clostridioides difficile isolates collected from private and public health settings in South Africa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  9. Article
  10. Article
  11. Mobilome of Environmental Isolates ofAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Potent Antimicrobial Activity ofAntibiotics (Basel, Switzerland) · 2025
    Article
  15. Microbial genomics · 2025
    Article
  16. Antimicrobial resistance ofOne health (Amsterdam, Netherlands) · 2024
    Article
  17. The complete catalog of antimicrobial resistance secondary active transporters inComputational and structural biotechnology journal · 2024
    Article
  18. EAVLD 2024 - 7Italian journal of food safety · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Keeley O'GradyCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
Daniel R KnightCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
Thomas V RileyCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia. thomas.riley@uwa.edu.au.
Murdoch University · AUQueen Elizabeth II Medical Centre · AUUniversity of Western Australia · AU

Funding

National Health and Medical Research Council APP1138257
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) in Clostridioides difficile remains a significant threat to global healthcare systems, not just for the treatment of C. difficile infection (CDI), but as a reservoir of AMR genes that could be potentially transferred to other pathogens. The mechanisms of resistance for several antimicrobials such as metronidazole and MLS

Indexed as

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsClostridioides difficileClostridium InfectionsHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial resistanceClostridioides difficileEpidemiologyGeneticsGenomePhenotype

Identifiers

PMID34427801
OpenAlexW3193436834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.